Nervous System Drugs Lag in Development, Approvals: Tufts

International Pharmaceutical Regulatory Monitor
A A
Drugs targeting the central nervous system take significantly longer to develop and get approved than other meds, according to a new analysis.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00